Skip to content

Chris Freeman, Chief Commercial Officer at Guardant Health, sold GH on Aug 10, 2026

Data as of Oct 16

▼ SELL$6M35,364 shares at $169.63Chris Freeman Chief Commercial OfficerGH Guardant Health, Inc.
Watch GH
Traded
Aug 10, 2026
Disclosed
Aug 11, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Chris Freeman, Chief Commercial Officer at Guardant Health, sold GH on Aug 10, 2026TRADEDDISCLOSED
GHSimilar stocks (XLV — its sector index fund), rebased to GH's price on the disclosure day
GH since disclosure
−3.9%
after the sale
Similar stocks (XLV) since disclosure
+5.2%
XLV — its sector index fund

Change in closing price from Aug 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChris Freeman Chief Commercial OfficerGH Guardant Health, Inc.$1.2Mdisclosed Aug 11 · filed 1 day after the trade
  2. ▼ SELLChris Freeman Chief Commercial OfficerGH Guardant Health, Inc.$580Kdisclosed Aug 11 · filed 1 day after the trade
  3. ▼ SELLChris Freeman Chief Commercial OfficerGH Guardant Health, Inc.$3Mdisclosed Aug 11 · filed 1 day after the trade

See every trade on GH →